Advertisement
Screener

GSK plc (GLAXF) Form 6-K: Report of foreign private issuer, 2019, Page 2

2.1 / 5 stars · 17/40 Roast Me

Add as a preferred source on Google

GSK plc Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2019-03-11: Form 6-K; Period of report 2019-03-11; Description DIRECTOR/PDMR SHAREHOLDING; Document a5173s.htm.
  • 2019-03-08: Form 6-K; Period of report 2019-03-08; Description VIIV POSITIVE PH3 DATA FOR LONG ACTING INJECTABLE; Document a2409s.htm.
  • 2019-03-05: Form 6-K; Period of report 2019-03-05; Description DIRECTOR/PDMR SHAREHOLDING; Document a9404r.htm.
  • 2019-03-01: Form 6-K; Period of report 2019-03-01; Description TOTAL VOTING RIGHTS; Document a5978r.htm.
FiledFormPeriod of reportDescriptionDocument
2019-03-116-K2019-03-11DIRECTOR/PDMR SHAREHOLDINGa5173s.htm
2019-03-086-K2019-03-08VIIV POSITIVE PH3 DATA FOR LONG ACTING INJECTABLEa2409s.htm
2019-03-056-K2019-03-05DIRECTOR/PDMR SHAREHOLDINGa9404r.htm
2019-03-016-K2019-03-01TOTAL VOTING RIGHTSa5978r.htm
2019-02-226-K2019-02-22DIRECTOR/PDMR SHAREHOLDINGa9280q.htm
2019-02-226-K2019-02-22GSK RESPONSE TO SFO STATEMENTa8889q.htm
2019-02-216-K2019-02-21DIRECTOR/PDMR SHAREHOLDINGa7926q.htm
2019-02-216-K2019-02-21DIRECTOR/PDMR SHAREHOLDINGa7899q.htm
2019-02-206-K2019-02-20DIRECTOR/PDMR SHAREHOLDINGa6489q.htm
2019-02-196-K2019-02-19DIRECTOR/PDMR SHAREHOLDINGa5168q.htm
2019-02-196-K2019-02-19DIRECTOR/PDMR SHAREHOLDINGa5123q.htm
2019-02-196-K2019-02-19DIRECTOR/PDMR SHAREHOLDINGa4084q.htm
2019-02-196-K2019-02-19DIRECTOR/PDMR SHAREHOLDINGa4013q.htm
2019-02-156-K2019-02-15DIRECTOR/PDMR SHAREHOLDINGa2807q.htm
2019-02-156-K2019-02-15DIRECTOR/PDMR SHAREHOLDINGa2811q.htm
2019-02-156-K2019-02-15DIRECTOR/PDMR SHAREHOLDINGa2796q.htm
2019-02-146-K2019-02-14DIRECTOR/PDMR SHAREHOLDINGa0324q.htm
2019-02-126-K2019-02-12DIRECTOR/PDMR SHAREHOLDINGa7996p.htm
2019-02-126-K2019-02-12DIRECTOR/PDMR SHAREHOLDINGa8003p.htm
2019-02-116-K2019-02-11DIRECTOR/PDMR SHAREHOLDINGa6581p.htm
2019-02-116-K2019-02-11DIRECTOR/PDMR SHAREHOLDINGa6583p.htm
2019-02-116-K2019-02-11DIRECTOR/PDMR SHAREHOLDINGa6578p.htm
2019-02-116-K2019-02-11DIRECTOR/PDMR SHAREHOLDINGa6531p.htm
2019-02-116-K2019-02-11DIRECTOR/PDMR SHAREHOLDINGa6529p.htm
2019-02-086-K2019-02-08DIRECTOR/PDMR SHAREHOLDINGa5291p.htm
2019-02-086-K2019-02-08DIRECTOR/PDMR SHAREHOLDINGa5292p.htm
2019-02-066-K2019-02-06FINAL RESULTSa2711pfr.htm
2019-02-066-K2019-02-06DIRECTOR/PDMR SHAREHOLDINGa2744p.htm
2019-02-056-K2019-02-05GSK AND MERCK ANNOUNCE GLOBAL ALLIANCE FOR M7824a1392p.htm
2019-02-016-K2019-02-01TOTAL VOTING RIGHTSa8832o.htm
2019-01-236-K2019-01-23DIRECTOR/PDMR SHAREHOLDINGa9137n.htm
2019-01-226-K2019-01-22GSK COMPLETES ACQUISITION OF TESAROa7941n.htm
2019-01-226-K2019-01-22GSK CHAIRMAN SUCCESSION PROCESSa6089n.htm
2019-01-156-K2019-01-15DIRECTOR/PDMR SHAREHOLDINGa1868n.htm
2019-01-156-K2019-01-15DIRECTOR/PDMR SHAREHOLDINGa1770n.htm
2019-01-156-K2019-01-15DIRECTOR/PDMR SHAREHOLDINGa1710n.htm
2019-01-156-K2019-01-15DIRECTOR/PDMR SHAREHOLDINGa1719n.htm
2019-01-156-K2019-01-15DIRECTOR/PDMR SHAREHOLDINGa1715n.htm
2019-01-156-K2019-01-15DIRECTOR/PDMR SHAREHOLDINGa1706n.htm
2019-01-156-K2019-01-15GLAXOSMITHKLINE EXTENDS TENDER OFFER FOR TESAROa1565n.htm
2019-01-116-K2019-01-11DIRECTOR/PDMR SHAREHOLDINGa9268m.htm
2019-01-116-K2019-01-11DIRECTOR/PDMR SHAREHOLDINGa9262m.htm
2019-01-026-K2019-01-02TOTAL VOTING RIGHTSa9866l.htm
Advertisement